You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | -230.2% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.2 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 22.0 |
| Price / Book value | -27.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | n/a | -16.93 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -21.18 | €-0.42 | -7.6 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 0.00 | -28.73 | €-0.52 | -6.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | n/a | -30.94 | €-0.48 | -7.3 | 0.0 | n/a | n/a | 0.0% |
| 2024-12-31 | n/a | -25.92 | €-0.29 | -8.5 | 0.0 | n/a | n/a | 0.0% |
| Faron enters financing arrangement with Heights Capital Management entity Sharecast News | 03 Apr |
|---|---|
| Faron identifies final patient in BEXMAB phase two study Sharecast News | 31 Jan |
| Faron Pharmaceuticals reports regulatory progress in the UK Sharecast News | 02 Dec |
| FDA Grants Orphan Drug Designation | 03-Mar-25 12:06 |
|---|---|
| Notice of Annual General Meeting | 28-Feb-25 22:57 |
| Positive EMA Opinion on Orphan Drug Designation | 27-Feb-25 07:30 |
| Annual Report 2024 published | 27-Feb-25 07:15 |
| Financial Statement 1 January to 31 December 2024 | 27-Feb-25 07:02 |